2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Puritas ≥99.0% (HPLC) Trelagliptin Succinate Intermedia Factory
Commercial Supple Trelagliptin Succinate Related Intermedia:
6-Chloro-3-Methyluracil CAS 4318-56-3
2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
Trelagliptin Succinate Intermediate-int D CAS 865759-246
Trelagliptin Succinate CAS 1029877-94-8
Please contact: alvin@ruifuchem.com
| Nomen chemicum | 2-Cyano-5-Flurobenzyl Bromide |
| Synonyma | 2-(Bromomethyl) -4-Fluorobenzonitrile |
| CAS Number | 421552-12-7 |
| CATTUS Number | RF-PI143 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C8H5BrFN |
| M. Pondus | 214.03 |
| Liquescens punctum | 67.0 ad 71.0℃ |
| Sensitiva | umorem Sensitivum |
| Solubilitas | Solutum in Methanol |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | White ad Off-Yellow pulveris |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Humor (KF) | ≤0.50% |
| Residere in Ignition | ≤0.30% |
| una immunditia | ≤0.50% |
| Totalis immunditias | ≤1.00% |
| 1 H NMR Spectrum | Congruunt cum Structure |
| Test Standard | Enterprise Standard |
| Consuetudinem | Trelagliptin Succinate (CAS: 1029877-94-8) Intermedia |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum 2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) magna qualitate, late in synthesi organica adhibita, synthesis intermedia pharmaceutica et medicamenta pharmaceutica activa. (API) synthesis.2-Cyano-5-Flurobenzyl Bromide adhiberi potest in synthesi Trelagliptin Succinate (CAS: 1029877-94-8).Trelagliptin Succinatus selectivus est, diu agens dipeptidylum peptidase-4 (DPP-4) inhibitor.Agens antidiabetic.Inhibitor ore activo DPP-4 qui efficit amet ac peraeque signanter emendationes glycemicae moderationis patientis cum 2 diabete typus.Trelagliptin Succinatus usus in Iaponia mense Martio MMXV probatus est.
